California Department of Insurance Intervenes in Lieff Cabraser’s Lawsuit Against AbbVie Alleging Kickbacks and Improper Marketing of Top-Selling Drug Humira

Hospital

Joint Complaint Filed Under the California Insurance Frauds Prevention Act

On September 18, 2018, Lieff Cabraser and California Insurance Commissioner Dave Jones sued AbbVie, Inc. for violations of the Insurance Frauds Prevention Act (“IFPA”) by providing kickbacks to healthcare providers throughout California relating to sale of the immunosuppressive drug Humira. Humira, used to treat arthritis, colitis, and other diseases, is a widely-prescribed drug that led the list of top-selling pharmaceutical products until its 2016 U.S. patent expiration, having global sales of $16 billion in 2016 alone. [Read more…]